Feifei Luo

机构：Fudan University, Huashan Hospital

发表论文 80 篇 · 总被引 2875 次 · h-index 29

代表论文

• Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy (2025 · Cancer Cell · 被引 88)
• Ganoderma lucidum Polysaccharide Supplementation Significantly Activates T-Cell-Mediated Antitumor Immunity and Enhances Anti-PD-1 Immunotherapy Efficacy in Colorectal Cancer (2024 · Journal of Agricultural and Food Chemistry · 被引 66)
• Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening (2023 · BMC Medicine · 被引 48)
• Foxp3 confers long-term efficacy of chimeric antigen receptor-T cells via metabolic reprogramming (2025 · Cell Metabolism · 被引 42)
• Cell metabolism-based optimization strategy of CAR-T cell function in cancer therapy (2023 · Frontiers in Immunology · 被引 40)
• Microbiota-derived butyrate alleviates asthma via inhibiting Tfh13-mediated IgE production (2025 · Signal Transduction and Targeted Therapy · 被引 38)